Braden M. Leonard - 20 Mar 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Mar 2024, 11:05:47 UTC
Prior SEC filing
19 Mar 2024
Next SEC filing
15 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Braden Michael Leonard

Key filing fact

Braden M. Leonard filed Form 4 for Cyteir Therapeutics, Inc. on 25 Mar 2024.

Key facts

  • This page summarizes Braden M. Leonard's Form 4 filing for Cyteir Therapeutics, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Mar 2024, 11:05.

Change

  • Previous filing in this sequence was filed on 19 Mar 2024.
  • Current net transaction value: +$503,238.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYT transaction

Common Stock, par value $0.001 per share

Purchase

Transaction value
$503,238
Shares
+170,589
Change %
+4.9%
Price
$2.95
Shares after
3,654,053
Date
20 Mar 2024
Ownership
Holding of BML Investment Partners, L.P
Footnotes
F1
CYT holding

Common Stock, par value $0.001 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
335,000
Date
20 Mar 2024
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.New Footnote

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .